E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Search
- Page Path
- HOME > Search
Letter to the Editor
- Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
- Sun Hyun Bae, Hee Chul Park
- J Liver Cancer. 2023;23(2):402-404. Published online September 8, 2023
- DOI: https://doi.org/10.17998/jlc.2023.08.18
- 685 Views
- 33 Downloads
Case Report
- A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy
- Jin Yong Lee, Jeong-Ju Yoo, Seong Joon Chun, Sun Hyun Bae, Jae Myeong Lee, Sang Gyune Kim, Young Seok Kim
- J Liver Cancer. 2020;20(1):78-83. Published online March 31, 2020
- DOI: https://doi.org/10.17998/jlc.20.1.78
- 4,814 Views
- 95 Downloads
-
Abstract
PDF - Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Additionally, hepatic arterial infusion chemotherapy has been used as a treatment option for advanced HCC. Here, we report a case of sustained partial response in a patient with advanced HCC with PVT after hepatic arterial infusion chemotherapy and radiation therapy.
First
Prev
Follow JLC on Twitter